The sixth Annual Blood-Brain Barrier Consortium Meeting is scheduled for April 27-29, 2000, at Timberline Lodge, Government Camp OR. Principle investigators, clinical staff, and researchers from the participating institutions of the Blood-Brain Barrier (BBB) Consortium have been invited to attend, as well as clinicians and researchers from other universities interested in assessing the importance of dose intensity in chemosensitive brain tumors. This ongoing annual meeting addresses the hypothesis that increased delivery of therapeutics in CNS malignancy can improve survival and quality of life without undue toxicity. The goals of the annual meeting are to review preclinical research advances, discuss clinical results and problems, and develop new clinical research protocols. Additionally, as at previous BBB Consortium meetings, this meeting will spotlight one or two areas of oncology or biology in which research advances may be impact brain tumor therapy. The topic of the 2000 meeting will be dose intensity"""""""", and two major areas will be discussed. (1) implementation of an international phase II study using two concurrent protocols comparing blood-brain barrier disruption chemotherapy with high-dose i.v. chemotherapy for the treatment of primary CNS lymphoma, and (2) potential development of a two-arm clinical study to assess the role of dose intensity in chemotherapy sensitive oligodendroglioma. This annual meeting will provide a forum for investigators working in the area of brain tumor therapy to meet fellow researchers from across the United States, learn about the Blood- Brain Barrier program and other new clinical approaches, translate preclinical research to the clinic, and develop protocols to determine optimal treatment strategies for chemo-sensitive brain tumors.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Conference (R13)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Wu, Roy S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
Schools of Medicine
United States
Zip Code
Brock, Penelope R; Maibach, Rudolf; Childs, Margaret et al. (2018) Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss. N Engl J Med 378:2376-2385
Doolittle, Nancy D; Muldoon, Leslie L; Culp, Aliana Y et al. (2014) Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances. Adv Pharmacol 71:203-43
Neuwelt, Edward A; Bauer, Björn; Fahlke, Christoph et al. (2011) Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 12:169-82
Angelov, Lilyana; Doolittle, Nancy D; Kraemer, Dale F et al. (2009) Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol 27:3503-9
Neuwelt, Edward; Abbott, N Joan; Abrey, Lauren et al. (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7:84-96
Muldoon, Leslie L; Soussain, Carole; Jahnke, Kristoph et al. (2007) Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol 25:2295-305
Doolittle, Nancy D; Peereboom, David M; Christoforidis, Gregory A et al. (2007) Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting. J Neurooncol 81:81-91
Muldoon, L L; Tratnyek, P G; Jacobs, P M et al. (2006) Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting. AJNR Am J Neuroradiol 27:715-21
Doolittle, Nancy D; Abrey, Lauren E; Bleyer, W Archie et al. (2005) New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting. Clin Cancer Res 11:421-8
Doolittle, Nancy D; Abrey, Lauren E; Ferrari, Nicolay et al. (2002) Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium. Clin Cancer Res 8:1702-9

Showing the most recent 10 out of 13 publications